Unilever plc vs Vir Biotechnology Inc. Common Stock — how do they compare? Unilever plc trades at $65.86 (market cap $137.84B), while Vir Biotechnology Inc. Common Stock trades at $10.52 (market cap $1.76B). The key difference: Unilever plc is far larger — about 78.3× Vir Biotechnology Inc. Common Stock's market cap, and Unilever plc pays a 3.32% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Unilever plc for 112 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| UL | VIR | |
|---|---|---|
Market Cap | $137.84B | $1.76B |
Volume | 2,711,415 | 2,764,948 |
Sector | Consumer Staples | Health |
52-Week High | $74.59 | $11.78 |
52-Week Low | $55.05 | $5.12 |
Typical Hold Time | 112 Days | 0 Days |
Enterprise Value | $162.87B | $1.32B |
Dividend Yield | 3.32% | — |
Signals from Pluang's Aura AI — not financial advice
Unilever (UL) trades at $62.49, down 0.73% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported strong Q2 2026 earnings with $50.5B revenue and $9.47B net income, though recent quarters have shown EPS misses against expectations. Unilever is undergoing significant portfolio transformation, including the planned $65B food business merger with McCormick, while focusing on beauty and personal care segments.
The stock presents a balanced risk-reward profile with 26% analyst buy ratings and a $66.08 consensus target offering 5.7% upside. Key opportunities include emerging market exposure and portfolio streamlining, while risks involve integration challenges from the McCormick deal and competitive pressures. Current valuation at 22.44 P/E appears reasonable given the company's 18.32% net margin and 54.56% ROE.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →